Abstract:BackgroundRecent data implicate the DNA-damage repair protein, BRCA1, as an essential regulator of cardiac structure and function. We hypothesized that BRCA1 regulates p53-mediated apoptotic cell death in cardiomyocytes and through this mechanism attenuates cardiac failure.Methods & resultsCardiomyocyte specific BRCA1 knockout mice (CM-BRCA1-/-) exhibited cardiac dysfunction with associated increased mortality in response to experimental myocardial infarction or genotoxic stress with doxorubicin. Increased total p53 expression was observed in the hearts of CM-BRCA1-/- mice relative to that in hearts from control littermates post-MI. The increase in cardiomyocyte apoptosis noted in CM-BRCA1+/− and CM-BRCA1-/- mice was associated with a loss of myocardial pro-survival Bcl-2 with concomitant increase in pro-apoptotic Bax leading to a ∼12.5 fold increase in the Bax:Bcl-2 ratio, hence shifting the balance from a survival to apoptotic milieu. This shift was further associated with elevated levels of total and cleaved caspase-3 compared to the corresponding control group. One of the first steps in the cellular response to double strand breaks (DSBs) is phosphorylation of histone H2A.X at Ser139 (γH2A.X). A ∼2.5-fold higher expression of γH2A.X was observed in hearts from CM-BRCA1-/- mice compared to control animals 48 h after experimental MI-induction. After three days, this DNA damage signal was resolved in control mice but a persistent γH2A.X signal was observed in the left ventricular sections of CM-BRCA1-/- mice. Although control mice exhibited evidence for post-MI RAD51-foci formation, such foci were largely absent from mice with cardiomyocyte-specific loss of BRCA1. To establish a role for p53 activation in the impaired cardiac stress response observed in BRCA1-deficient mice, we crossed αMHC-Cretg/;BRCA1fl/fl mice with p53+/− mutants to generate mice with deletion of one allele of BRCA1 in their cardiomyocytes along with the systemic loss of one allele of p53 (αMHC-Cretg/;BRCA1fl/+;p53+/− otherwise denoted as CM-BRCA1+/−;p53+/−). CM-BRCA1+/−;p53+/− mice were protected against ischemia-induced apoptosis and cardiac failure compared to CM-BRCA1+/− mice. We also generated compound heterozygous BRCA1+/Δ11;p53+/− mice and found that systemic loss of one allele of p53 rescued BRCA1+/Δ11 heterozygous mice against ischemia-induced cardiac dysfunction.ConclusionLoss of BRCA1 provokes ischemia-induced cardiomyocyte apoptosis through alterations in the p53-mediated cell death pathway, which is causally implicated in ischemic heart failure. BackgroundRecent data implicate the DNA-damage repair protein, BRCA1, as an essential regulator of cardiac structure and function. We hypothesized that BRCA1 regulates p53-mediated apoptotic cell death in cardiomyocytes and through this mechanism attenuates cardiac failure. Recent data implicate the DNA-damage repair protein, BRCA1, as an essential regulator of cardiac structure and function. We hypothesized that BRCA1 regulates p53-mediated apoptotic cell death in cardiomyocytes and through this mechanism attenuates cardiac failure. Methods & resultsCardiomyocyte specific BRCA1 knockout mice (CM-BRCA1-/-) exhibited cardiac dysfunction with associated increased mortality in response to experimental myocardial infarction or genotoxic stress with doxorubicin. Increased total p53 expression was observed in the hearts of CM-BRCA1-/- mice relative to that in hearts from control littermates post-MI. The increase in cardiomyocyte apoptosis noted in CM-BRCA1+/− and CM-BRCA1-/- mice was associated with a loss of myocardial pro-survival Bcl-2 with concomitant increase in pro-apoptotic Bax leading to a ∼12.5 fold increase in the Bax:Bcl-2 ratio, hence shifting the balance from a survival to apoptotic milieu. This shift was further associated with elevated levels of total and cleaved caspase-3 compared to the corresponding control group. One of the first steps in the cellular response to double strand breaks (DSBs) is phosphorylation of histone H2A.X at Ser139 (γH2A.X). A ∼2.5-fold higher expression of γH2A.X was observed in hearts from CM-BRCA1-/- mice compared to control animals 48 h after experimental MI-induction. After three days, this DNA damage signal was resolved in control mice but a persistent γH2A.X signal was observed in the left ventricular sections of CM-BRCA1-/- mice. Although control mice exhibited evidence for post-MI RAD51-foci formation, such foci were largely absent from mice with cardiomyocyte-specific loss of BRCA1. To establish a role for p53 activation in the impaired cardiac stress response observed in BRCA1-deficient mice, we crossed αMHC-Cretg/;BRCA1fl/fl mice with p53+/− mutants to generate mice with deletion of one allele of BRCA1 in their cardiomyocytes along with the systemic loss of one allele of p53 (αMHC-Cretg/;BRCA1fl/+;p53+/− otherwise denoted as CM-BRCA1+/−;p53+/−). CM-BRCA1+/−;p53+/− mice were protected against ischemia-induced apoptosis and cardiac failure compared to CM-BRCA1+/− mice. We also generated compound heterozygous BRCA1+/Δ11;p53+/− mice and found that systemic loss of one allele of p53 rescued BRCA1+/Δ11 heterozygous mice against ischemia-induced cardiac dysfunction. Cardiomyocyte specific BRCA1 knockout mice (CM-BRCA1-/-) exhibited cardiac dysfunction with associated increased mortality in response to experimental myocardial infarction or genotoxic stress with doxorubicin. Increased total p53 expression was observed in the hearts of CM-BRCA1-/- mice relative to that in hearts from control littermates post-MI. The increase in cardiomyocyte apoptosis noted in CM-BRCA1+/− and CM-BRCA1-/- mice was associated with a loss of myocardial pro-survival Bcl-2 with concomitant increase in pro-apoptotic Bax leading to a ∼12.5 fold increase in the Bax:Bcl-2 ratio, hence shifting the balance from a survival to apoptotic milieu. This shift was further associated with elevated levels of total and cleaved caspase-3 compared to the corresponding control group. One of the first steps in the cellular response to double strand breaks (DSBs) is phosphorylation of histone H2A.X at Ser139 (γH2A.X). A ∼2.5-fold higher expression of γH2A.X was observed in hearts from CM-BRCA1-/- mice compared to control animals 48 h after experimental MI-induction. After three days, this DNA damage signal was resolved in control mice but a persistent γH2A.X signal was observed in the left ventricular sections of CM-BRCA1-/- mice. Although control mice exhibited evidence for post-MI RAD51-foci formation, such foci were largely absent from mice with cardiomyocyte-specific loss of BRCA1. To establish a role for p53 activation in the impaired cardiac stress response observed in BRCA1-deficient mice, we crossed αMHC-Cretg/;BRCA1fl/fl mice with p53+/− mutants to generate mice with deletion of one allele of BRCA1 in their cardiomyocytes along with the systemic loss of one allele of p53 (αMHC-Cretg/;BRCA1fl/+;p53+/− otherwise denoted as CM-BRCA1+/−;p53+/−). CM-BRCA1+/−;p53+/− mice were protected against ischemia-induced apoptosis and cardiac failure compared to CM-BRCA1+/− mice. We also generated compound heterozygous BRCA1+/Δ11;p53+/− mice and found that systemic loss of one allele of p53 rescued BRCA1+/Δ11 heterozygous mice against ischemia-induced cardiac dysfunction. ConclusionLoss of BRCA1 provokes ischemia-induced cardiomyocyte apoptosis through alterations in the p53-mediated cell death pathway, which is causally implicated in ischemic heart failure. Loss of BRCA1 provokes ischemia-induced cardiomyocyte apoptosis through alterations in the p53-mediated cell death pathway, which is causally implicated in ischemic heart failure.

728 BRCA1 Induces Cardiac Protection Through a P53-dependent Pathway

BRCA1 is an Essential Regulator of Heart Function and Survival Following Myocardial Infarction

Metabolomic and transcriptomic studies of improvements in myocardial infarction due to Pycr1 deletion

53BP1 Loss Rescues Embryonic Lethality but Not Genomic Instability of BRCA1 Total Knockout Mice

Cardiomyocyte specific deletion of p53 decreases cell injury during ischemia-reperfusion: Role of Mitochondria

Atm-Chk2-P53 Activation Prevents Tumorigenesis At An Expense Of Organ Homeostasis Upon Brca1 Deficiency

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis

Hypersensitivity of Brca1-Deficient Mef to the Dna Interstrand Crosslinking Agent Mitomycin C is Associated with Defect in Homologous Recombination Repair and Aberrant S-Phase Arrest

Absence Of Full-Length Brca1 Sensitizes Mice To Oxidative Stress And Carcinogen-Induced Tumorigenesis In The Esophagus And Forestomach

A Selective Requirement for 53BP1 in the Biological Response to Genomic Instability Induced by Brca1 Deficiency.

BRG1 Deficiency Promotes Cardiomyocyte Inflammation and Apoptosis by Activating the cGAS-STING Signaling in Diabetic Cardiomyopathy

Impaired Skin And Mammary Gland Development And Increased Gamma-Irradiation-Induced Tumorigenesis In Mice Carrying A Mutation Of S1152-Atm Phosphorylation Site In Brca1

BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest

P53 Acetylation Exerts Critical Roles In Pressure Overload Induced Coronary Microvascular Dysfunction and Heart Failure

Synergistic regulation of p53 by Mdm2 and Mdm4 is critical in cardiac endocardial cushion morphogenesis during heart development.

Data from Impaired Skin and Mammary Gland Development and Increased γ-Irradiation–Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1

The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes

Impaired Meiotic DNA-damage Repair and Lack of Crossing-over During Spermatogenesis in BRCA1 Full-Length Isoform Deficient Mice

DNA-PKcs Promotes Cardiac Ischemia Reperfusion Injury Through Mitigating BI-1-governed Mitochondrial Homeostasis

p53 Acetylation Exerts Critical Roles in Pressure Overload–Induced Coronary Microvascular Dysfunction and Heart Failure in Mice

Endothelial Cell-specific Loss of Breast Cancer Susceptibility Gene 2 Exacerbates Atherosclerosis